The quarantine authorities said they have secured sufficient supplies of COVID-19 oral treatments in Korea and will continue to consider additional purchases depending on the quarantine situation. The quarantine authorities also said they would consider using the budget for purchasing Regkirona as an oral drug as Regkirona, an antibody treatment for COVID-19, is known to be vulnerable to responding to Omikron mutations. On the 14th, the KDCA responded in writing to the National Assembly's Health and Welfare Committee's Seo Young-seok of the Democratic Party and Lee Jong-sung of the People's Power.

Rep. Seo asked if it was possible to secure PO drugs such as Paxlovid and expand the number of additional p